FindMyRecallSubscribe
Class I: serious health riskTerminated

Allergan Taytulla Softgel Capsules Recall

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample…

Allergan, PLC. · Madison, NJ

Risk level
Class I
Reported by FDA
Jun 20, 2018
Recall ID
D-0875-2018
Check your lot numberHow we source this data

Summary

Allergan recalled Allergan Taytulla Softgel Capsules starting May 24, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0875-2018 on Jun 20, 2018. Reason: Contraceptive Tablets Out of Sequence. Status: Terminated.

Why it was recalled

Contraceptive Tablets Out of Sequence.

Product description

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Lot numbers, UPCs & expiration codes

Lot# 5620706, Exp. 05/19

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0875-2018
Classification
Class I
Status
Terminated
Recall initiated
May 24, 2018
FDA report date
Jun 20, 2018
Quantity
168,768 blister cards (4,725,504 softgel capsules)
Recall type
Voluntary: Firm initiated
Recalling firm
Allergan, PLC.

Original FDA data

Every field from FDA enforcement report D-0875-2018, exactly as published.

Show all FDA fields
City
Madison
State
NJ
Status
Terminated
Country
United States
Event ID
80136
Address
5 Giralda Farms
Code information
Lot# 5620706, Exp. 05/19
Postal code
07940-1027
Report date
Jun 20, 2018
Product type
Drugs
Recall number
D-0875-2018
Classification
Class I
Recalling firm
Allergan, PLC.
Product quantity
168,768 blister cards (4,725,504 softgel capsules)
Termination date
May 19, 2022
Reason for recall
Contraceptive Tablets Out of Sequence.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290
Distribution pattern
US Nationwide
Recall initiation date
May 24, 2018
Initial firm notification
Letter
Center classification date
Jun 15, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0875-2018, published Jun 20, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls